MakoLab (WAR:MLB) YoY EBITDA Growth: -49.45% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MLB MakoLab SA WAR:MLB
80 GF Score
Price zł7.40
GF Value zł5.16
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is MakoLab YoY EBITDA Growth?

MakoLab WAR:MLB -2.63% 80 YoY EBITDA Growth is -49.45% as of Jun. 2026. GuruFocus rates WAR:MLB with a GF Score™ of 80/100 and a GF Value™ of zł5.16 (Significantly Overvalued). The stock has 1 warning sign investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MakoLab's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -49.45%.

MakoLab's EBITDA per Share for the three months ended in Jun. 2026 was zł0.18.

MakoLab YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for MakoLab's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MakoLab YoY EBITDA Growth Chart

MakoLab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.26 61.93 -30.26 78.71 -13.81

MakoLab Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.91 1,827.78 -73.09 136.15 -49.45
WAR:MLB
80GF Score
MakoLab SA WAR:MLB
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MakoLab YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MakoLab's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.955-1.108)/ | 1.108 |
=-13.81 %

MakoLab's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.183-0.362)/ | 0.362 |
=-49.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -49.45% mean?
MakoLab (WAR:MLB) has a YoY EBITDA Growth of -49.45% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for MakoLab and its competitors.
Is MakoLab's YoY EBITDA Growth too high?
MakoLab's current YoY EBITDA Growth is -49.45%. Overall, MakoLab has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MakoLab's YoY EBITDA Growth compare to IBM and ACN?
MakoLab's YoY EBITDA Growth of -49.45% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Software company?
A good YoY EBITDA Growth depends on the Software industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for MakoLab and its competitors. MakoLab's current YoY EBITDA Growth is -49.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MakoLab stock overvalued right now?
Based on GuruFocus' analysis, MakoLab (WAR:MLB) is currently considered Significantly Overvalued. The stock's GF Value™ is zł5.16, compared to a current price of zł7.40 — trading 43.4% above its estimated fair value. The current YoY EBITDA Growth is -49.45%. MakoLab's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For MakoLab (WAR:MLB), the current YoY EBITDA Growth is -49.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MakoLab (WAR:MLB) Overvalued in 2026?

Based on GuruFocus' analysis, MakoLab stock appears to be overvalued. The current stock price of zł7.40 is trading 43.4% above its estimated GF Value™ of zł5.16. GuruFocus considers MakoLab to be Significantly Overvalued.

Key valuation signals for WAR:MLB:

  • YoY EBITDA Growth: -49.45%
  • GF Value™: zł5.16 vs. price of zł7.40 (43.4% above fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the WAR:MLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MakoLab Business Description

Address ul. Ogrodowa 8, Lodz, POL, 91-062
MakoLab SA engaged in the provision of technology and marketing solutions in Poland. It is engaged in the creation and implementation of Web solutions, including Web services, portals, WWW pages, and visual projects; and provision of maintenance and management services of IT resources. The company serves Automotive, Finance, Banking and Insurance, Commercial Real Estate, Public sector, Culture and Education, Lifestyle, and Tourism, Travelling and Leisure.
80GF Score

Get the complete analysis for WAR:MLB

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.40
Price
zł5.16
GF Value